Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hanover
Clinical trial register · Germany

Clinical Trials in Hanover, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5060 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:18 UTC
5060
Studies in scope
all four open statuses
2879
Recruiting now
open to new participants
987
Lead sponsors
across recruiting studies
Top sites
Berlin 45 Essen 30 Hamburg 30 Dresden 22 Leipzig 22
Narrow the registerReset
Recruitment status
Phase
Site location
Berlin45 Essen30 Hamburg30 Dresden22 Leipzig22
All 110 locations
Target enrolment
to

Trials with a site in Hanover

16 of 5060 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Eli Lilly and Company
Phase 3
2,001
Berlin, Bochum, Hanover, Hohenmölsen, Karlsruhe, Leipzig, Obertshausen, Offenbach
2026-08-26
Recruiting
Eli Lilly and Company
Phase 3
800
Bamberg, Berlin, Essen, Hanover, Karlsruhe, Marburg, Oldenburg, Schwerin
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
300
Hanover, Hof, Karlsburg, Ludwigshafen am Rhein, München, Oldenburg, Sankt Augustin, Ulm
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
150
Augsburg, Dresden, Hanover, München
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bad Oeynhausen, Berlin, Brandenburg, Dresden, Düsseldorf, Frankfurt, Hanover, Heidelberg
2025-10-15
Active, closed
Eli Lilly and Company
Phase 3
800
Bochum, Dresden, Hamburg, Hanover, Karlsruhe, Leipzig, München, Offenbach
2025-09-15
Recruiting
Eli Lilly and Company
Phase 3
350
Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
2025-06-26
Active, closed
Eli Lilly and Company
Phase 2
143
Augsburg, Berlin, Brandenburg an der Havel, Duisburg, Frankfurt am Main, Halle, Hamburg, Hanover
2024-10-10
Active, closed
Eli Lilly and Company
Phase 3
152
Heidelberg, Löwenstein, Gauting, München, Immenhausen, Georgsmarienhütte, Hanover, Münster
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
874
Ludwigsburg, Donauwörth, Erlangen, München, Frankfurt am Main, Hanover, Essen, Mönchengladbach
2021-10-04
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
Eli Lilly and Company
Phase 1
260
Hanover
2020-11-19
Active, closed
Eli Lilly and Company
Phase 3
996
Pforzheim, Würzburg, Frankfurt am Main, Lauterbach, Hanover, Bottrop, Wipperfürth, Leipzig
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,058
Berlin, Brandenburg, Halle, Hamburg, Hanover, Ludwigshafen
2018-07-18
Active, closed
Eli Lilly and Company
Phase 2
309
Tübingen, Ulm, Erlangen, Hanover, Berlin, Hamburg
2016-05-19
Active, closed
Eli Lilly and Company
Phase 3
453
Berlin, Gera, Großhansdorf, Hamburg, Hanover, Heidelberg, Immenhausen, Nuremberg
2014-10-03
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-germany/city/hanover

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,060 studies in total at the last sync on 14 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Hanover that also match the filters currently applied.

How many clinical trials are recruiting in Hanover?

7 of the 16 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hanover), 16 studies
PhaseStudiesRecruitingShare
Phase 313781.3%
Phase 22012.5%
Phase 1106.3%

Most active sponsors

Lead sponsors with the most studies (Hanover)
Lead sponsorStudiesRecruiting
Eli Lilly and Company167
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.